Verampil is a calcium channel blocker prescribed for the treatment of hypertension and certain cardiac arrhythmias. It functions by inhibiting the influx of calcium ions into vascular smooth muscle and cardiac myocytes through l-type channels. This inhibition reduces the force of cardiac contraction and slows the heart rate, leading to decreased myocardial oxygen demand. The resulting vasodilation lowers peripheral vascular resistance and thereby reduces blood pressure. The combined effect improves blood flow and alleviates symptoms associated with angina and arrhythmic episodes. Overall the medication provides therapeutic benefit by modulating calcium mediated cellular activity in the cardiovascular system.

Verampil is a medication that belongs to the class of calcium channel blockers. It is formulated for oral administration and works by influencing the flow of calcium across cardiac and vascular cells. By reducing the amount of calcium that enters these cells the drug causes relaxation of blood vessel walls. This relaxation leads to a widening of the vessels which lowers resistance to blood flow. The resulting decrease in vascular resistance helps to lower arterial pressure and improve oxygen delivery to the heart. In addition the drug can affect the heart's electrical activity making it useful for managing certain types of irregular rhythms. The overall effect of these actions is a therapeutic reduction in blood pressure and a decreased workload on the heart. Verampil thus serves as a pharmacological tool that modifies calcium signaling to achieve its intended cardiovascular benefits.

Common side effects of Verampil include constipation and dizziness. Headache and flushing may also occur. Some patients experience swelling of the ankles or feet. Fatigue is reported in a small number of cases. Nausea can be observed in certain individuals. These effects are generally mild to moderate in intensity.

Verampil may cause dizziness and lightheadedness especially when standing up quickly. It can also lead to swelling of the ankles or feet due to fluid retention. Some patients report mild headaches accompanied by occasional fatigue. The medication sometimes produces a slow heartbeat or irregular pulse that requires monitoring. Digestive disturbances such as nausea or constipation are occasionally observed. Sensitivity to sunlight may develop causing increased skin redness or irritation.